Public Support Conditions

How it works

Preparation

Risks & contraindications

Highlighted claims

• Participant support for AI and opt-out consent depended on transparency, GDPR compliance, medical-research-only use, and accessible opt-out mechanisms. — Opinions of the UK general public and stroke survivors in using artificial intelligence and ‘opt-out’ models of consent in medical research: a qualitative study
• Participants' concerns about commercial use were addressed by confirming that data would be used only for medical research and not shared with commercial organisations. — Opinions of the UK general public and stroke survivors in using artificial intelligence and ‘opt-out’ models of consent in medical research: a qualitative study
• The study implemented participant feedback by broadening opt-out advertising, creating a local opt-in register, and establishing an oversight group. — Opinions of the UK general public and stroke survivors in using artificial intelligence and ‘opt-out’ models of consent in medical research: a qualitative study
• Public concerns about AI can be reduced through education, transparency, and established ethical, legal, and governance frameworks. — Opinions of the UK general public and stroke survivors in using artificial intelligence and ‘opt-out’ models of consent in medical research: a qualitative study
• Trust in the institution conducting research affects public support for opt-out consent. — Opinions of the UK general public and stroke survivors in using artificial intelligence and ‘opt-out’ models of consent in medical research: a qualitative study